BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ZL-82 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ZL-82\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07193589-51@assetmemo.bio
DTSTAMP:20261121T005707Z
DTSTART;VALUE=DATE:20271230
DTEND;VALUE=DATE:20271231
SUMMARY:ZL-82: Phase 2 readout est. (NCT07193589)
DESCRIPTION:ZL-82\, phase 2\, Atopic Dermatitis.\nStudy: A Phase II Clinica
 l Study Evaluating of ZL-82 Tablets in Atopic Dermatitis\nEstimated primar
 y completion: 30 December 2027. This is a ClinicalTrials.gov estimate\, no
 t a confirmed readout date\, and it can move.\nDrug page: https://assetmem
 o.bio/drug/zl-82#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT07193589
URL:https://assetmemo.bio/drug/zl-82#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
